(Q36093284)

12 August 2017

1 reference

title

Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions (English)

1 reference

12 August 2017

0 references

1 reference

1 reference

Dene Simpson

1

1 reference

12 August 2017

Stuart Noble

series ordinal

2

1 reference

12 August 2017

publication date

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

65

1 reference

12 August 2017

issue

6

1 reference

12 August 2017

page(s)

827-858

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200565060-00011

12 August 2017

exact match

0 references

cites work

Topical tacrolimus treatment of atopic eyelid disease

1 reference

12 December 2020

Direct evidence that FK506 inhibition of FcepsilonRI-mediated exocytosis from RBL mast cells involves calcineurin

1 reference

12 December 2020

Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells

1 reference

12 December 2020

Eczema herpeticum during treatment of atopic dermatitis with 0.1% tacrolimus ointment

1 reference

12 December 2020

Combination therapy of tetracycline and tacrolimus resulting in rapid resolution of steroid-induced periocular rosacea

1 reference

12 December 2020

Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis

1 reference

12 December 2020

Tacrolimus ointment is effective for facial and intertriginous psoriasis

1 reference

12 December 2020

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis.

1 reference

12 December 2020

Childhood Vitiligo and Tacrolimus

1 reference

12 December 2020

Long-term efficacy and safety of topical tacrolimus in the management of ulcerative/erosive oral lichen planus.

1 reference

12 December 2020

Successful treatment of erosive vulvovaginal lichen planus with topical tacrolimus

1 reference

12 December 2020

Recalcitrant symptomatic vulvar lichen planus: response to topical tacrolimus

1 reference

12 December 2020

Repigmentation of vitiligo with topical tacrolimus

1 reference

12 December 2020

Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety.

1 reference

12 December 2020

Molluscum contagiosum in atopic dermatitis treated with 0.1% tacrolimus ointment

1 reference

12 December 2020

Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children

1 reference

12 December 2020

Topical tacrolimus: a new therapy for atopic dermatitis.

1 reference

12 December 2020

Repigmentation of chronic vitiligo lesions by following tacrolimus plus ultraviolet‐B–narrow‐band

1 reference

12 December 2020

Effect of tacrolimus hydrate (FK506) ointment on spontaneous dermatitis in NC/Nga mice

1 reference

12 December 2020

New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use.

1 reference

12 December 2020

Kaposi varicelliform eruption associated with 0.1% tacrolimus ointment treatment in atopic blepharitis

1 reference

12 December 2020

Immunomodulatory macrolactams for topical treatment of inflammatory skin diseases.

1 reference

12 December 2020

Tacrolimus ointment in the treatment of eyelid dermatitis.

1 reference

12 December 2020

Long-term safety of tacrolimus ointment in children treated for atopic dermatitis

1 reference

12 December 2020

Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections

1 reference

12 December 2020

Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment

1 reference

12 December 2020

A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo

1 reference

12 December 2020

Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies

1 reference

12 December 2020

An open trial of topical tacrolimus for erosive oral lichen planus

1 reference

12 December 2020

Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children

1 reference

12 December 2020

Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus

1 reference

12 December 2020

Tacrolimus effect on rosacea

1 reference

12 December 2020

Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation

1 reference

12 December 2020

Effects of cyclosporin A and FK-506 on stem cell factor-induced histamine secretion and growth of human mast cells

1 reference

12 December 2020

Tacrolimus ointment for atopic dermatitis

1 reference

12 December 2020

Topical tacrolimus and pimecrolimus: future directions

1 reference

12 December 2020

A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis

1 reference

12 December 2020

Tacrolimus: a review of its use for the management of dermatoses

1 reference

12 December 2020

Tacrolimus ointment: utilization patterns in children under age 2 years.

1 reference

12 December 2020

Atopic dermatitis management with tacrolimus ointment (Protopic ® )

1 reference

12 December 2020

Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study

1 reference

12 December 2020

Combination therapy and new directions for managing atopic dermatitis

1 reference

12 December 2020

Endogenous superallergen protein Fv induces IL-4 secretion from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE

1 reference

12 December 2020

1 reference

12 December 2020

Pimecrolimus: a review of its use in atopic dermatitis

1 reference

12 December 2020

Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report

1 reference

12 December 2020

Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis.

1 reference

12 December 2020

Regulation of interleukin-5 production by peripheral blood mononuclear cells from atopic patients with FK506, cyclosporin A and glucocorticoid

1 reference

12 December 2020

The macrolide immunosuppressants in dermatology: mechanisms of action.

1 reference

12 December 2020

Novel therapies for atopic eczema

1 reference

12 December 2020

A rosacea-like granulomatous eruption in a patient using tacrolimus ointment for atopic dermatitis

1 reference

12 December 2020

A case of generalized pustular psoriasis treated with topical tacrolimus.

1 reference

12 December 2020

Safe treatment of head/neck AD with tacrolimus ointment

1 reference

12 December 2020

0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial

1 reference

12 December 2020

Topical tacrolimus: an effective therapy for facial psoriasis

1 reference

12 December 2020

The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis

1 reference

12 December 2020

Unexpected high serum levels of tacrolimus after a single topical application in an infant

1 reference

12 December 2020

Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506).

1 reference

12 December 2020

Tacrolimus ointment for the treatment of atopic dermatitis

1 reference

12 December 2020

Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation

1 reference

12 December 2020

Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment

1 reference

12 December 2020

Topical immunomodulators for atopic dermatitis

1 reference

12 December 2020

Systematic review of treatments for atopic eczema.

1 reference

12 December 2020

Tacrolimus ointment for the management of atopic dermatitis

1 reference

12 December 2020

Anti-tumor-promoting action of FK506, a potent immunosuppressive agent.

1 reference

12 December 2020

Immunosuppressive macrolides of the type FK 506: a novel class of topical agents for treatment of skin diseases?

1 reference

12 December 2020

A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group

1 reference

12 December 2020

Grading of the severity of atopic dermatitis.

1 reference

12 December 2020

Topical tacrolimus ointment may induce skin tags in treated patients

1 reference

12 December 2020

Effects of 1-year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitis

1 reference

12 December 2020

Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group

1 reference

12 December 2020

Antiinflammatory effect of FK 506 on human basophils

1 reference

12 December 2020

Deep dermatophytosis during topical tacrolimus therapy for psoriasis

1 reference

12 December 2020

Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation

1 reference

12 December 2020

Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis

1 reference

12 December 2020

Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids).

1 reference

12 December 2020

Tacrolimus ointment: its place in the therapy of atopic dermatitis

1 reference

12 December 2020

Facial eruption of molluscum contagiosum during topical treatment of atopic dermatitis with tacrolimus.

1 reference

12 December 2020

Topical fluticasone propionate: a review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders

1 reference

12 December 2020

Relapsing Kaposi's varicelliform eruption and herpes simplex following facial tacrolimus treatment for atopic dermatitis

1 reference

12 December 2020

Recalcitrant erosive flexural lichen planus: successful treatment with a combination of thalidomide and 0.1% tacrolimus ointment

1 reference

12 December 2020

Clinical applications of cytokines: new directions in the therapy of atopic diseases.

1 reference

12 December 2020

Does topical tacrolimus induce lentigines in children with atopic dermatitis? A report of three cases.

1 reference

12 December 2020

Tacrolimus (FK506) ointment for atopic dermatitis: a phase I study in adults and children

1 reference

12 December 2020

Topical tacrolimus in the treatment of symptomatic oral lichen planus: a series of 13 patients.

1 reference

12 December 2020

New treatments for atopic dermatitis

1 reference

12 December 2020

Topical tacrolimus for repigmentation of vitiligo

1 reference

12 December 2020

Tacrolimus 0.1% ointment for seborrhoeic dermatitis: an open-label pilot study

1 reference

12 December 2020

The role of topical calcineurin inhibitors in atopic dermatitis

1 reference

12 December 2020

Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases

1 reference

12 December 2020

Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin

1 reference

12 December 2020

Macrolactam immunomodulators for topical treatment of inflammatory skin diseases

1 reference

12 December 2020

Mode of action of tacrolimus (FK506): molecular and cellular mechanisms.

1 reference

12 December 2020

Disease management of atopic dermatitis: a practice parameter. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Counci

1 reference

12 December 2020

A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients

1 reference

12 December 2020

Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas

1 reference

12 December 2020

Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases

1 reference

12 December 2020

Successful treatment of vitiligo with 0.1% tacrolimus ointment

1 reference

12 December 2020

Modulation of histamine release in vitro by FK506 and interleukin-3 is determined by sequence of incubation

1 reference

12 December 2020

Adults with atopic dermatitis and herpes simplex and topical therapy with tacrolimus: what kind of prevention?

1 reference

12 December 2020

Tacrolimus ointment (Protopic) for atopic dermatitis.

1 reference

12 December 2020

FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells

1 reference

12 December 2020

Tacrolimus ointment: a new therapy for atopic dermatitis--review of the literature.

1 reference

12 December 2020

Successful treatment of erosive lichen planus with topical tacrolimus

1 reference

12 December 2020

Topical tacrolimus 0.1% ointment (protopic) reverses nickel contact dermatitis elicited by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema

1 reference

12 December 2020

Erosive mucosal lichen planus: response to topical treatment with tacrolimus

1 reference

12 December 2020

Tacrolimus ointment for the treatment of atopic dermatitis: clinical and pharmacologic effects

1 reference

12 December 2020

[Effects of tacrolimus ointment on type I (immediate and late) and IV (delayed) cutaneous allergic reactions in mice]

1 reference

12 December 2020

Eczema molluscatum in tacrolimus treated atopic dermatitis

1 reference

12 December 2020

Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis

1 reference

12 December 2020

Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study

1 reference

12 December 2020

Phenotyping of epidermal dendritic cells: clinical applications of a flow cytometric micromethod

1 reference

12 December 2020

Topical tacrolimus for the treatment of inflammatory skin diseases

1 reference

12 December 2020

The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis

1 reference

12 December 2020

Effects of tacrolimus ointment on facial eruption, itch, and scratching in patients with atopic dermatitis

1 reference

12 December 2020

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group

1 reference

12 December 2020

Anti-inflammatory effect of FK-506 on human skin mast cells

1 reference

12 December 2020

Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis

1 reference

12 December 2020

An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis

1 reference

12 December 2020

Annular erythema responding to tacrolimus ointment.

1 reference

12 December 2020

A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis

1 reference

12 December 2020

Atopic dermatitis: pathogenetic mechanisms

1 reference

12 December 2020

Tacrolimus pharmacology and nonclinical studies: from FK506 to protopic

1 reference

12 December 2020

Topical tacrolimus is effective for facial lesions of psoriasis

1 reference

12 December 2020

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis

1 reference

12 December 2020

Staphylococcal colonization in atopic dermatitis treatment with topical tacrolimus (Fk506).

1 reference

12 December 2020

Comparison of the effects of daily applications between topical corticosteroid and tacrolimus ointments on normal skin: evaluation with noninvasive methods

1 reference

12 December 2020

Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study

1 reference

12 December 2020

Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy

1 reference

12 December 2020

Topical tacrolimus for treatment of childhood vitiligo in Asians.

1 reference

12 December 2020

Safety of the new macrolide immunomodulators

1 reference

12 December 2020

Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis

1 reference

12 December 2020

FK506 inhibition of histamine release and cytokine production by mast cells and basophils

1 reference

12 December 2020

Tacrolimus ointment improves psoriasis in a microplaque assay

1 reference

12 December 2020

Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial

1 reference

12 December 2020

Viral infections in atopic dermatitis Pathogenic aspects and clinical management

1 reference

12 December 2020

Increased Topical Tacrolimus Absorption in Generalized Leukemic Erythroderma

1 reference

12 December 2020

Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitis

1 reference

12 December 2020

Calcineurin inhibitors and sirolimus: mechanisms of action and applications in dermatology.

1 reference

12 December 2020

Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series.

1 reference

12 December 2020

Pharmacoeconomics of drug therapy for atopic dermatitis

1 reference

12 December 2020

Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions

1 reference

12 December 2020

Topical FK506: suppression of allergic and irritant contact dermatitis in the guinea pig.

1 reference

12 December 2020

A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group

1 reference

12 December 2020

Tacrolimus enhances irritation in a 5-day human irritancy in vivo model

1 reference

12 December 2020

Atopic dermatitis: review of immunopathogenesis and advances in immunosuppressive therapy

1 reference

12 December 2020

Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506, and rapamycin

1 reference

12 December 2020

Intermittent topical corticosteroid/tacrolimus sequential therapy improves lichenification and chronic papules more efficiently than intermittent topical corticosteroid/emollient sequential therapy in patients with atopic dermatitis

1 reference

12 December 2020

Inhibition of contact allergy reactions by topical FK506.

1 reference

12 December 2020

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis.

1 reference

12 December 2020

10.2165/00003495-200565060-00011

Identifiers

DOI

1 reference

Dimensions Publication ID

12 August 2017

1046848367

0 references

1 reference